TREATMENT SIDE EFFECTS
Clinical trials for TREATMENT SIDE EFFECTS explained in plain language.
Never miss a new study
Get alerted when new TREATMENT SIDE EFFECTS trials appear
Sign up with your email to follow new studies for TREATMENT SIDE EFFECTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Body's own cells deployed against advanced breast cancer in new trial
Disease control Recruiting nowThis study tests a treatment called TIL therapy for people with advanced breast cancer who have run out of standard options. Doctors take immune cells from a patient's tumor, grow them in a lab, and put them back into the body after a short chemotherapy. The goal is to shrink tum…
Matched conditions: TREATMENT SIDE EFFECTS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 16, 2026 22:33 UTC
-
Could your own tumor cells beat cancer? new trial launches
Disease control Recruiting nowThis early-stage study tests a treatment using a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight advanced solid tumors. About 30 adults who have not responded to standard treatments will receive these cells along with chemotherapy. The main goal…
Matched conditions: TREATMENT SIDE EFFECTS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 16, 2026 22:32 UTC
-
Engineered immune cells take on pancreatic cancer in first human test
Disease control Recruiting nowThis early-phase study tests a new treatment called GC203 TIL for people with pancreatic cancer that has not responded to standard therapies. The treatment uses a patient's own immune cells, which are collected from their tumor, genetically modified to fight cancer better, and th…
Matched conditions: TREATMENT SIDE EFFECTS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 16, 2026 22:31 UTC
-
Immune cells from tumors could be new weapon against Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment for people with advanced liver or pancreatic cancers that have not responded to standard therapies. The treatment uses immune cells taken from the patient's own tumor, grown in large numbers in a lab, and then given back to the patient. The goal i…
Matched conditions: TREATMENT SIDE EFFECTS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 16, 2026 22:27 UTC
-
Immune cells supercharged to fight advanced skin cancer
Disease control Recruiting nowThis study tests a treatment made from a patient's own immune cells (called TILs) to fight advanced melanoma. Doctors take a sample of the tumor, grow the immune cells in a lab, and then put them back into the patient. The goal is to shrink tumors and control the cancer, but pati…
Matched conditions: TREATMENT SIDE EFFECTS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Engineered immune cells take on tough gynecologic tumors
Disease control Recruiting nowThis early-stage study tests a new treatment called GC201 TIL for people with advanced gynecologic cancers that have not responded to standard therapies. Doctors take immune cells from the patient's tumor, modify them to better fight cancer, and then return them to the body. The …
Matched conditions: TREATMENT SIDE EFFECTS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Scissors vs. electrosurgery: which is better for uterine septum removal?
Symptom relief Recruiting nowThis study compares two surgical techniques for removing a uterine septum, a wall of tissue inside the uterus that can cause problems. Researchers want to see if using scissors without electricity is better than using an electric tool. The study will measure surgery time, costs, …
Matched conditions: TREATMENT SIDE EFFECTS
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 16, 2026 22:31 UTC